2026/01/01 by Francesca Binacchi, Martina Porco, Tiziana Funaioli +7 · 1 voice
Medicine · Chemistry · #Metal complexes synthesis and properties #Chemotherapy-induced cardiotoxicity and mitigation #Metal-Catalyzed Oxygenation Mechanisms
paper · doi:10.1039/d6dt00471g
openalex publication_date 2026/01/01 · openalex created_date 2026/03/27 · openalex updated_date 2026/07/16
cyclic voltammetry. Reduction assays with dithiothreitol confirmed efficient Pt(IV) → Pt(II) conversion on timescales compatible with physiological conditions. Cytotoxicity studies on human ovarian carcinoma A2780 cells under normoxic and hypoxic environments highlighted increased activity under hypoxia, suggesting preferential prodrug activation in a reducing tumour-like milieu. Asymmetrical complexes generally offered improved solubility and promising antiproliferative profiles, whereas certain monobromoacetate-containing derivatives displayed partial instability linked to the higher leaving group ability of bromide. Notably, mechanistic investigations indicated that the enhanced cytotoxicity of selected bromoacetate-functionalised complexes is not associated with increased DNA damage relative to oxaliplatin, suggesting the contribution of additional non-genomic pathways. These findings emphasise the promise of monohaloacetate-functionalised oxaliplatin(IV) complexes as multimodal prodrugs combining platinum-mediated cytotoxicity with complementary bioactive mechanisms for improved anticancer efficacy.